Related Experiment Videos
[Proarrhythmic effects of anti-arrhythmia agents]
P Scanu1, D Agostini, G Grollier
1Service de soins intensifs de cardiologie, hôpital Côte-de-Nacre, CHRU de Caen, France.
La Revue De Medecine Interne
|January 1, 1995
Summary
Antiarrhythmic drugs can paradoxically cause new or worsen existing arrhythmias in 10-20% of patients. Careful monitoring and benefit-risk analysis are crucial due to these unpredictable proarrhythmic effects.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Medicine
Context:
- Antiarrhythmic medications are essential for managing ventricular and supraventricular arrhythmias.
- Despite their efficacy, these drugs carry significant risks, including severe side effects.
Purpose:
- To highlight the paradoxical proarrhythmic effects of antiarrhythmic drugs.
- To discuss the mechanisms, detection, and management of these adverse events.
Summary:
- Antiarrhythmic drugs can induce or worsen arrhythmias in 10-20% of patients, a phenomenon termed 'proarrhythmia'.
- The CAST study demonstrated increased mortality in post-myocardial infarction patients treated with certain antiarrhythmics, largely attributed to proarrhythmic effects.
- Mechanisms vary by drug class and arrhythmia type, involving factors like altered ion channel function and reentry facilitation.
- Detection is challenging, relying on ECG, Holter monitoring, treadmill tests, and electrophysiologic studies.
Impact:
- Clinicians must be aware of proarrhythmic risks, especially in patients with impaired left ventricular function.
- Thorough benefit-risk assessment and vigilant patient monitoring are essential when prescribing antiarrhythmic medications.
- Understanding these unpredictable, non-toxicity-related effects is critical for patient safety and effective arrhythmia management.